Keep up to date with MTPConnect news and events, updated regularly. If you have news or events the sector would be interested to hear about, please let us know at email@example.com.
31 October 2018
New report: Australia poised for global success in regenerative medicine
A new report on opportunities for Australia’s burgeoning regenerative medicine sector reveals it has all the elements needed to be a global leader and drive the creation of thousands of new, high paying jobs.
26 October 2018
MTPConnect and Life Sciences Queensland extend collaboration agreement
MTPConnect, the national growth centre for the medical technology, biotechnology and pharmaceutical sector, and Queensland peak industry group Life Sciences Queensland have expanded their alliance to help grow Australian life sciences.
25 October 2018
Two MTPConnect projects attract outside investment
The CSIRO protein production platform in Melbourne and the Medical Device Partnering Program (MDPP) based at Flinders University in Adelaide are the latest MTPConnect projects to attract additional investment from Australian State governments.
24 October 2018
Cancer Therapeutics CRC signs agreement to enable Pfizer to develop novel cancer drugs
Melbourne-headquartered Cancer Therapeutics CRC (CTx) announced a two-year research collaboration and a license agreement with Pfizer Inc. (NYSE: PFE).
10 October 2018
New Funding to boost Australian Healthtech Sector
Three key life sciences projects have been awarded a total of $690,000 in new funding to support researchers, improve collaboration with industry and open-up international market opportunities.
09 October 2018
Australian Health Innovations on Show to the World
From virtual reality for kids to novel surgical equipment Australia’s health innovations under development will be on display to the world at the World Hospital Congress in Brisbane.
03 October 2018
New Chair for MTPConnect
Sue MacLeman has commenced as Chair of MTPConnect, the Medical Technologies and Pharmaceuticals Industry Growth Centre.
02 October 2018
MDPP Launches Itself into Victoria
MTPConnect congratulates our Project Fund Program recipient The Medical Device Partnering Program (MDPP) on expanding its operations into Victoria. It has received support from LaunchVic, a government agency helping to kickstart the Victorian start-up environment.
01 October 2018
MTP sector’s role in driving trade and investment: taking the message to Canberra
In August, MTPConnect CEO Dr Dan Grant gave evidence to the Parliamentary Inquiry into Australia’s trade system and the digital economy conducted by the Joint Standing Committee on Trade and Investment Growth.
28 September 2018
Australia enhances relationship with influential US healthtech association
MTPConnect has expanded its alliance with the influential The Medical Alley Association of Minnesota to open-up linkages for Australian researchers and firms in the United States.
27 September 2018
Australian government growth centers invest in life sciences sector for future global growth
PERTH, Australia – The Australian government’s Medical Technology, Biotechnology and Pharmaceutical Industry Growth Center (MTPConnect) launched a new node in Western Australia.
26 September 2018
Opening international markets: MTPConnect Australian pavilion officially open at the 2018 MedTech Conference!
MTPConnect is leading a delegation of 19 Australian companies, which includes a range of research organisations, universities and industry bodies.
24 September 2018
MTPConnect opening opportunities in WA
Earlier this month, MTPConnect – in partnership with the Western Australian Government and the University of Western Australia (UWA) – officially opened the MTPConnect WA Hub in Perth.
19 September 2018
Accelerating Australia invited by Finnish government and SPARK Finland to join strategic planning workshop
Two Accelerating Australia executives were recently flown to Helsinki to join international MTP commercialisation experts in a 2-day strategic planning roundtable.
10 September 2018
Australian-first approach to cancer trials to improve patient care
An Australian-first approach to cancer clinical trials – called registry-based randomised controlled trials or registry trials – will enhance the ability of clinicians to select the right treatments for patients.